Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 USD | -0.36% | +4.10% | -15.43% |
05-20 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
05-06 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.43% | 305M | |
+16.54% | 122B | |
+20.24% | 115B | |
+21.43% | 26.64B | |
-23.06% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.35% | 15.49B | |
+59.40% | 14.83B | |
+2.61% | 13.67B |
- Stock Market
- Equities
- FHTX Stock
- News Foghorn Therapeutics Inc.
- Foghorn® Therapeutics Appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer